Novel Drug Discovery
Use molecular interaction intelligence to support new candidate discovery.
Molecular Fingerprint™ Platform narrows the search for novel drugs and new patient populations.
The current public site positions AI as the engine that transforms big data into prioritized candidates and supports a proteome-wide discovery approach.
HOW IT WORKS
From big data to better-informed candidates.
01
Map
Evaluate candidate interactions across a broad curated protein-target collection.
02
Fingerprint
Build a molecular interaction view that captures on-target and off-target behavior.
03
Prioritize
Identify candidates and insights that can inform synthesis, optimization and testing.
04
Translate
Support decisions across discovery, preclinical work and clinical development.
CORE CAPABILITIES
Designed to address the full interaction landscape.
Selectivity & Safety
Assess potential off-target interactions and toxicity-related signals.
Phenotypic Target Deconvolution
Help identify targets from phenotypic assay results.
Polypharmacology Prediction
Understand the broader interaction profile of a candidate.
Drug Repurposing
Explore target-disease combinations for potential repurposing opportunities.
Mutation Effects
Explore how target mutations may affect drug binding.